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Background: The German national nosocomial infection surveillance system, KISS, has a component for very low
birth weight (VLBW) infants (called NEO-KISS) which changed from a system with voluntary participation and
confidential data feedback to a system with mandatory participation and confidential feedback.
Methods: In order to compare voluntary and mandatory surveillance data, two groups were defined by the
surveillance start date. Neonatal intensive care unit (NICU) parameters and infection rates of the NICUs in both
groups were compared. In order to analyze the surveillance effect on primary bloodstream infection rates (BSI), all
VLBW infants within the first three years of participation in both groups were considered. The adjusted effect
measures for the year of participation were calculated.
Results: An increase from 49 NICUs participating in 2005 to 152 in 2006 was observed after the introduction of
mandatory participation. A total of 4280 VLBW infants was included in this analysis. Healthcare-associated incidence
densities rates were similar in both groups. Using multivariate analysis with the endpoint primary BSI rate and
comparing the first and third year of participation lead to an adjusted incidence rate ratio (IRR) of 0.78 (CI95 0.66-0.93)
for old (voluntary) and 0.81 (CI95 0.68-0.97) for new (mandatory) participants.
Conclusions: The step from a voluntary to a mandatory HCAI surveillance system alone may lead to substantial
improvements on a countrywide scale.
Keywords: Surveillance, Nosocomial infections, Neonatal intensive care unit, Bloodstream infectionBenchmarking of healthcare associated infections
(HCAI) surveillance data has been used for many years
in many countries to inform preventive strategies and
reduce infection rates. Most national surveillance sys-
tems were started on a voluntary basis and with confi-
dential data feedback to the participating hospitals, but
due to huge media and patient interest, mandatory par-
ticipation and public reporting of HCAI have been
meanwhile implemented in many countries.* Correspondence: frank.schwab@charite.de
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reproduction in any medium, provided the orThe German national nosocomial infection surveil-
lance system (KISS) was established in 1997, using the
example of the U.S. National Nosocomial Infections Sur-
veillance (NNIS) system, and focusing on ICU and post-
surgery patients. As in the NNIS system, KISS was set
up with voluntary participation and confidential data
feedback to participating units. In 2000, a further sur-
veillance component for very low birth weight (VLBW)
infants was established (NEO-KISS), which is also on the
basis of voluntary participation and confidential data
feedback. It focuses on primary bloodstream infections
(BSI) and pneumonia. BSI and pneumonia rates are stan-
dardized according to device use and stratified by 3 birth
weight categories (< 500 g, 500–999 g, 1000–1499 g).l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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“Gemeinsamer Bundesausschuss”, a joint committee of
German healthcare providers and health insurance com-
panies, required participation by all neonatal departments
caring for VLBW on a mandatory basis in NEO-KISS in
order to receive reimbursement. Public reporting of infec-
tion rates was not required. From the viewpoint of the
organizers of NEO-KISS, it was interesting to investigate
how this modification would influence infection rates and
the use of surveillance data for reduction of nosocomial
infections. In particular, two questions should be
addressed:
 Would mandatory instead of voluntary participation
in the surveillance system lead to lower sensitivity in
diagnosing HCAI and therefore to lower reference
data with a lower value for benchmarking?
 Would mandatory instead of voluntary participation
lead to less intensive use of surveillance data to
improve HCAI rates in individual units?Methods
NEO-KISS is a patient-based surveillance method for
VLBW that includes patients in surveillance until a
weight of 1800 g is achieved, if they do not die or are
transferred earlier. The detailed surveillance method
used in NEO-KISS is described elsewhere [1], [2]. It
can also be found under www.nrz-hygiene.de/en/
surveillance/hospital-infection-surveillance-system/neo-
kiss/ together with the latest reference data. The follow-
ing variables were collected for all patients: birth weight,
sex, multiple birth, gestational age and type of delivery.
Cases of primary bloodstream infections (BSI) and pneu-
monia were determined using modified CDC definitions
[2]. Surveillance persons from each neonatal intensive
care unit (NICU) have to attend an introductory course
before starting data collection where the definitions are
explained and trained with case studies.Definitions and selection criteria for analyzed NICUs
In order to compare voluntary and mandatory surveil-
lance data, two groups were defined by the surveillance
start date of the first patient within a single NICU and
the time of surveillance between the first and last patient.
Group 1 consisted of the old participants with volun-
tary participation. They started patient surveillance be-
tween January 2000 and December 2002 and participated
continuously for 3 years (1095 days) in NEO-KISS. 26
NICUs met this criterion.
Group 2 consisted of the new participants with
mandatory participation. They started with patient surveil-
lance between January and December 2006 and participated
continuously for 3 years. 95 NICUs met this criterion.Influence on infection rates
To answer the first question, data from 2007 were exam-
ined. NICU parameters and infection rates of the NICUs
in both groups were compared by Chi-square or Wil-
coxon rank sum test.Influence on surveillance effect
To stimulate further infection control measures, all
NICUs participating received a biannual feedback report
including crude and standardized infection rates of their
own NICU compared with the national reference data
until 2006. From 2007 on, a web-based data entry with
the possibility of immediate data calculation and feed-
back has been employed. Problems of surveillance were
discussed and prevention activities were shared at annual
workshops. Because primary BSI is the most frequent
HCAI in VLBW infants, the influence of participation in
the surveillance system on HCAI rates focused on the in-
cidence density of primary BSI. In an earlier investigation
of 24 units during their first three years of continuous
participation, a significant decrease in BSI between first
and third year of participation was found [3].
For the second question, all VLBW-infants within the
first three years of participation in both groups were
considered. In the univariable analysis, primary BSI inci-
dence densities in the individual years of participation
were determined and compared. The relative risks (RR)
and their 95% confidence intervals (CI95) were calcu-
lated. In the multivariable analysis, logistic regression
and Poisson regression models were performed to iden-
tify significant risk factors for the occurrence of BSI. The
following parameters were considered: birth weight (5
categories, 250 g steps), gestational age (4 categories,
<27/27-28/29-30/>30 weeks), sex, mode of delivery
(sectio, emergency sectio), multiple birth, surveillance
end point (3 categories: 1800 g/transfer/died), and
VLBW-volume year 2007 (≤/>30 VLBW infants). In the
Poisson regression model, the log number of patient days
was treated as offset parameter for number BSI. All para-
meters were considered in a full model and model para-
meters were excluded stepwise by the smallest chi-square
value and p≥ 0.05 in the type III test. The adjusted effect
measures for the year of participation were calculated by
generalized estimating equation (GEE) models that con-
sider cluster effects within a NICU. In this model, all sig-
nificant parameters from the first model building step
were included. However, for face validity reasons, we
added sex into all final models. The quasi-likelihood in-
formation criterion (QIC) as a modification of the Akaike
information criterion (ACI) was used as goodness-of-fit
measure in the GEE model. P values of less than 0.05
were considered significant. All analyses were performed
with SPSS (IBM SPSS Statistics; IBM Corporation,
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Our study was based on surveillance data. All data
were anonymous and collected in accordance with the
German recommendations of good epidemiological
praxis with respect to data protection. As a federal law,
the German Protection against Infection Act (Infek-
tionsschutzgesetz }23) regulates the prevention and
management of infectious disease in humans. All hospi-
tals are obliged to collect and analyse continuously noso-
comial infections and resistant pathogens. These routine
data were reported to the National Reference Centre of
the Surveillance of Nosocomial Infections. Ethical ap-
proval and informed consent were thus not required.
Results
From the beginning in 2000 until 2005, a constant in-
crease of the number of participating neonatal units was
observed during the period of voluntary participation.
Almost all remaining German neonatal ICUs caring for
VLBW infants joined NEO-KISS after the introduction
of mandatory participation. Figure 1 gives an overview
about the annual number of participating neonatal units.
An increase from 49 units participating in 2005 to 152 in
2006 was observed after the introduction of mandatory
participation. At present, 220 centers submit data to
NEO-KISS.
Influence on infection rates
Table 1 shows NICU characteristics; distribution of very
low birth weight (VLBW) infants according to birth
weight groups; device utilization rates; and nosocomial
infection and NEC incidence rates in the groups of old
(voluntary participation) and new participants (mandatory
participation) for the period from January to December
2007. A total of 4280 VLBW infants was considered for
this analysis, with 1527 from the old participants and





































Figure 1 Development of the annual number of participating
neonatal intensive care units (NICU) in NEO-KISS.differ significantly. Old participants have lower mean
birth weight, have more VLBW infants per year, higher
numbers of NICU beds and transfer patients more fre-
quently before achieving 1800 g. However, healthcare-
associated incidence densities rates are similar, with the
exception of a significantly lower primary BSI rate in
the birth weight group of 500-999 g in the group of new
participants. Device-associated infection rates differ
accordingly.
Influence on surveillance effect
Table 2 describes the development of NICU characteris-
tics and BSI rates during the first three years of partici-
pation in the surveillance system in both groups. The
univariable comparison of primary BSI incidence density
reveals a relative risk of 0.79 (CI95 0.68-0.91) in the first
group and of 0.79 (CI95 0.69-0.90) in the second group
also. Using multivariate analysis with the endpoint inci-
dence density of primary BSI leads to an adjusted inci-
dence rate ratio (IRR) of 0.78 (CI95 0.66-0.93) for the
first group and 0.81 (CI95 0.68-0.97) for the second
group (Table 3).
Discussion
The transition from a voluntary to a mandatory surveil-
lance system did not lead to lower quality of reference
data and also did not influence the use of surveillance
data for reducing nosocomial infections, at least in the
field of neonatal intensive care medicine [4]. Even those
NICUs not interested in participating in a voluntary sur-
veillance system were able to record HCAI with a simi-
lar sensitivity and specificity and were also able to use
the data for reducing HCAI rates to the same extent as
NICUs with voluntary participation and therefore prob-
ably more interest in this subject. This is interesting be-
cause one could argue that NICUs participating on a
voluntary basis are more likely to be interested and en-
thusiastic about quality improvement than those who
are forced to gather and report HCAI data. Accordingly,
volunteers might be more amenable to participation in
training and validation exercises, produce higher quality
data and achieve better patient outcomes [5]. But this
seems not to be the case. After starting surveillance on a
mandatory basis, the healthcare workers responsible for
surveillance seem to be as interested and as stimulated
as those in units with an interest from the beginning.
However, the data of this mandatory surveillance sys-
tem are still confidential. Only the head of each depart-
ment receives their data together with the reference data
and can decide how to use the information. Many coun-
tries have meanwhile introduced mandatory participa-
tion in combination with public reporting instead of
voluntary participation and confidential data feedback.
For example, many US states use the NHSN system as a
Table 1 Characteristics of NICU surveillance data in 26 old/voluntary and 95 new/mandatory participants in NEO-KISS,
year 2007
Parameter Old/voluntary participants
(N= 26, starting in NEO-KISS
1January 2000- December 2002)
New/mandatory participants




Number of beds in the NICU, median 24 16 0.004
Number of VLBW infants year 2007, median 53 23 <0.001
Months of participation until December 2010, median 123 56 <0.001
Number VLBW infants 1527 2753
Birth weight (gram), mean 1100 1140 0.001
End of surveillance
Transfer before 1800 g 21.4% 13.10% <0.001b
End of surveillance 1800 g 71.9% 80.0%
Died 6.7% 7.0%
Number VLBW infants according to birth weight groups (%)
< 500 g 52 (3.4%) 92 (3.3%) 0.069b
1000-1499 g 615 (40.3%) 1012 (36.8%)
1000-1499 g 860 (56.3%) 1649 (59.9%)
Device utilization rates per 100 patient days (pooled mean)#
CVC
500-999 g 28.2 30.2 0.484
1000-1499 g 13.8 16.9 0.934
Tube
500-999 g 21.2 21.2 0.267
1000-1499 g 6.3 6.1 0.676
Healthcare associated infection rates per 1000 patient days (pooled mean)#
Primary BSI
500-999 g 6.5 5.2 0.023
1000-1499 g 3.1 3.2 0.964
Pneumonia
500-999 g 1.0 0.8 0.286
1000-1499 g 0.4 0.1 0.053
Device-associated infection rates per 1000 device days (pooled mean)#
CVC-BSI
500-999 g 11.4 9.4 0.011
1000-1499 g 7.7 6.9 0.150
Tube associated pneumonia
500-999 g 2.2 2.3 0.634
1000-1499 g 3.9 0.4 0.010
NICU, neonatal intensive care unit; BSI, bloodstream infection; CVC-BSI, Central venous catheter-associated bloodstream infection; VLBW, very low birth weight;
# Data for the birth weight group< 500 g are not shown because of the small number of VLBW infants in this group; a p-value, Wilcoxon test; b p-value, Chi
square test.
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NHSN data from 2006 for neonatal ICUs with the data
for 2010 shows a significant decrease of primary BSI
rates from many HCAI rates can be found (from 5.2 to
2.3 in the birth weight group 751-1000 g and from 3.4 to1.4 in the birth weight group 1001–1500, Level II/III)
[6], [7]. However, it remains an open question if this is
due to real success in decreasing HCAI rates or due to
underreporting because of public reporting. Therefore it
seems to be interesting that the process from a voluntary
Table 2 Development of primary BSI rates during the first three years of participation in 26 old/voluntary and 95 new/
mandatory participants in NEO-KISS
Old/voluntary participants (N= 26, starting
in NEO-KISS January 2000- December 2002)
New/mandatory participants (N= 95, starting
in NEO-KISS January-December 2006)
1st year 2nd year 3rd year Total 1st year 2nd year 3rd year Total
Number of VLBW infants 1421 1310 1207 3938 2855 2740 2676 8271
Pooled mean birth weight (g) 1070 1125 1085 1095 1145 1140 1146 1140
Number of patient days 59314 52112 48651 160077 103198 100382 98416 301996
Mean observation days per patient 41.7 39.8 40.3 40.6 36.1 36.6 36.8 36.5
CVC utilization rates (%) 21.2 22.1 22.6 21.9 24.9 24.2 22.7 24.0
Number of BSI 456 347 294 1097 509 439 384 1332
BSI Incidence density (per 1000 patient days) 7.7 6.7 6.0 6.9 4.9 4.4 3.9 4.4
NICU, neonatal intensive care unit; BSI, bloodstream infection; VLBW, very low birth weight.
Table 3 Results of univariable and multivariable analysis comparing primary BSI rates the 3rd and 1st year of
participation in NEO-KISS
HCAI infection rate Old/voluntary participants (N= 26, starting in NEO-KISS
January 2000- December 2002)
New/mandatory participants (N= 95, starting in NEO-KISS
January-December 2006)
univariable analysis pooled








(per 1000 patient days)
RR = 0.79; (CI95 0.68-0.91);
p = 0.001
IRRa = 0.78; (CI95 0.66-0.93);
p = 0.005
RR =0.79; (CI95 0.69-0.90);
p< 0.001
IRRa = 0.81; (CI95 0.68-0.97);
p = 0.019
CI95, 95% confidence interval; RR, relative risk; IRR, adjusted incidence rate ratio; p, p-value;
a Poisson regression models with the outcome number BSI and log number patient days as offset parameter calculated by generalized estimating equation (GEE)
model which account for clustering effect within a single NICU, consider the following parameters: birth weight (5 categories, 250gram steps), gestational age (4
categories, <27/27-28/29-30/>30 weeks), sex, mode of delivery (sectio) and surveillance endpoint (3 categories: 1800 g/transfer/died).
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decreased reference data quality.
This analysis has some limitations
 Both groups are not really comparable, because
many structural parameters differed between both
groups. It may be that larger centers that transfer
more patients after the critical period had a higher
interest from the beginning in participating in a
surveillance system. These differences may also
explain the significantly lower BSI rates in the birth
weight group 500–999 g.
 The comparison of HCAI rates in old and new
participating NICUs is biased by the fact that at
least 26 of the old participants have already achieved
a significant decrease of BSI rates in their first three
years of participation.
 The reduction of BSI rates during the observation
periods may result not only from the surveillance
effect but also from medical and technological
achievements in this time period.
In conclusion, the step from a voluntary to a
mandatory HCAI surveillance system alone may lead to
substantial improvements. Awareness of HCAI increasesin all comparable institutions, and HCAI identification
skills are improving on a countrywide scale. Employing
infection rate calculation and interpretation to stimulate
infection control activities has also improved.
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